What is the total market value of global deep hole drilling machines market report?

The global deep hole drilling machines market size was valued at $611.1 million in 2019 and is projected to reach $784.1 million by 2027, registering a CAGR of 6.2% from 2020 to 2027. Deep hole drilling machines are utilized for drilling holes with depth-to-diameter (D:d) more than 10:1 and up to 400:1. It is especially designed for manufacturing of accurate and straight drilled workpieces, which find application in various industries, including automotive parts, medical and surgical tools, aerospace & defense related parts, and others.

How can I get report sample of deep hole drilling machines market?

To get latest version of deep hole drilling machines market report can be obtained on demand from the website.

Which is base year calculated in the global deep hole drilling machines market report?

The global deep hole drilling machines market size was valued at $611.1 million in 2019 and is projected to reach $784.1 million by 2027, registering a CAGR of 6.2% from 2020 to 2027. Deep hole drilling machines are utilized for drilling holes with depth-to-diameter (D:d) more than 10:1 and up to 400:1. It is especially designed for manufacturing of accurate and straight drilled workpieces, which find application in various industries, including automotive parts, medical and surgical tools, aerospace & defense related parts, and others.

Global Spinal Muscular Atrophy (SMA) Treatment Market Report By Type (Type 1, Type 2, Type 3, And Type 4), Treatment (Gene Therapy, And Drug), Route Of Administration (Oral, And Intrathecal) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2020-2027

ID:VMR11210467

January 2020

As per this study, the Global Spinal Muscular Atrophy (SMA) Treatment Market was valued USD XX MN (by revenue) in 2019 and is anticipated to reach USD XX MN by 2026 with a CAGR of XX%.

Spinal Muscular Atrophy (SMA) is a hereditary disease affecting the part of the nervous system that controls voluntary muscle movement. SMA disables people of physical strength by affecting the motor nerve cells of the spinal cord, taking away ability to eat, walk or breathe. It is the genetic cause of infant death globally. SMA affects 1 in 11,000 babies approximately. The only drug approved for the treatment of SMA is Spinraza. An alternative to this, gene therapy is another treatment used to treat SMA.

Market Dynamics

The increasing awareness by various NGO’s and the public regarding Spinal Muscular Atrophy (SMA) and a growing number of initiatives to improve treatment for rare diseases are fueling the market growth of SMA treatment. Moreover, improving the healthcare sector is again boosting the market growth. However, the high cost of treatment and lack of experienced professionals are some of the factors that restrain market growth. Whereas, innovation of more efficient drugs and therapies is expected to offer opportunities to SMA treatment market in the forecast period.

This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of spinal muscular atrophy (SMA) treatment.

Market Segmentation

The broad spinal muscular atrophy (SMA) treatment market has been sub-grouped into type, treatment and route of administration. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Type

Type 1
Type 2
Type 3
Type 4

By Treatment

Gene Therapy
Drug

By Route Of Administration

Oral
Intrathecal

Regional Analysis

Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for spinal muscular atrophy (SMA) treatment in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.

Europe Spinal Muscular Atrophy (SMA) Treatment Market By Revenue (USD MN)

The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the spinal muscular atrophy (SMA) treatment market includes Avexis, Inc., Biogen, Cytokinetics, Inc., F. Hoffmann - La Roche Ltd, Ionis Pharmaceuticals, Inc., and Novartis AG. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

METHODOLOGY:

A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Spinal Muscular Atrophy (Sma) Treatment Market
       2.2. Global Spinal Muscular Atrophy (Sma) Treatment Market Snapshot

3 . SPINAL MUSCULAR ATROPHY (SMA) TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Spinal Muscular Atrophy (Sma) Treatment Market
       3.3. Market Restraints of Spinal Muscular Atrophy (Sma) Treatment Market
       3.4. Opportunities of Spinal Muscular Atrophy (Sma) Treatment Market
       3.5. Trends of Spinal Muscular Atrophy (Sma) Treatment Market
       3.6. Porter’s Five Force Analysis of Spinal Muscular Atrophy (Sma) Treatment Market
       3.7. Spinal Muscular Atrophy (Sma) Treatment Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Treatment
           3.7.3 Market Attractive Analysis by Route Of Administration
           3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Spinal Muscular Atrophy (Sma) Treatment Value Chain Analysis
       4.2. Spinal Muscular Atrophy (Sma) Treatment Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Spinal Muscular Atrophy (Sma) Treatment Raw Material Manufactures List
           4.2.3. Price Trend of Spinal Muscular Atrophy (Sma) Treatment Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . GLOBAL SPINAL MUSCULAR ATROPHY (SMA) TREATMENT MARKET ANALYSIS BY TYPE
       5.1 Overview by Type
       5.2 Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis by Type
       5.3 Market Analysis of Type 1 by Regions
       5.4 Market Analysis of Type 2 by Regions
       5.5 Market Analysis of Type 3 by Regions
       5.6 Market Analysis of Type 4 by Regions

6 . GLOBAL SPINAL MUSCULAR ATROPHY (SMA) TREATMENT MARKET ANALYSIS BY TREATMENT
       6.1 Overview by Treatment
       6.2 Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis by Treatment
       6.3 Market Analysis of Gene Therapy by Regions
       6.4 Market Analysis of Drug by Regions

7 . GLOBAL SPINAL MUSCULAR ATROPHY (SMA) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
       7.1 Overview by Route Of Administration
       7.2 Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis by Route Of Administration
       7.3 Market Analysis of Oral by Regions
       7.4 Market Analysis of Intrathecal by Regions

8 . GLOBAL SPINAL MUSCULAR ATROPHY (SMA) TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Spinal Muscular Atrophy (Sma) Treatment Market Estimate by Country
           8.3.3. United State
           8.3.4. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Spinal Muscular Atrophy (Sma) Treatment Market Estimate by Market Segment
           8.4.3. Europe Spinal Muscular Atrophy (Sma) Treatment Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Spinal Muscular Atrophy (Sma) Treatment Market Estimate by Market Segment
           8.5.3. Asia Pacific Spinal Muscular Atrophy (Sma) Treatment Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.7. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Spinal Muscular Atrophy (Sma) Treatment Market Estimate by Market Segment
           8.6.3. Latin America Spinal Muscular Atrophy (Sma) Treatment Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview
           8.7.2. Middle East & Africa Spinal Muscular Atrophy (Sma) Treatment Market Estimate by Market Segment
           8.7.3. Middle East & Africa Spinal Muscular Atrophy (Sma) Treatment Market Estimate by Country
           8.7.4. Middle East
           8.7.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE SPINAL MUSCULAR ATROPHY (SMA) TREATMENT COMPANIES
       9.1. Spinal Muscular Atrophy (Sma) Treatment Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments

10 . COMPANY PROFILES OF SPINAL MUSCULAR ATROPHY (SMA) TREATMENT INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Avexis, Inc.
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Biogen
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Cytokinetics, Inc.
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. F. Hoffmann - La Roche Ltd
         10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Ionis Pharmaceuticals, Inc.
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Novartis AG
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments

11. IMPACT ANALYSIS OF COVID-19 OUTBREAK
11.1. Impact Analysis of Covid-19 Outbreak on the Market
11.1.1. Direct Impact on Production
11.1.2. Supply Chain and Market Disruption
11.1.3. Financial Impact on Firms and Financial Markets
11.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
11.3. Pre V/S Post COVID-19 Market
11.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
11.5. COVID-19: Micro and Macro Factor Analysis on the Market

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Spinal Muscular Atrophy (Sma) Treatment Report
Market Research Process
Market Research Methodology
Global Spinal Muscular Atrophy (Sma) Treatment Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Type
Market Attractiveness Analysis by Treatment
Market Attractiveness Analysis by Route Of Administration
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis by Type (USD MN)
Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis in Type 1 by Geography (USD MN)
Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis in Type 2 by Geography (USD MN)
Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis in Type 3 by Geography (USD MN)
Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis in Type 4 by Geography (USD MN)
Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis by Treatment (USD MN)
Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis in Gene Therapy by Geography (USD MN)
Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis in Drug by Geography (USD MN)
Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis by Route Of Administration (USD MN)
Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis in Oral by Geography (USD MN)
Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis in Intrathecal by Geography (USD MN)
Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis in by Geography (USD MN)
Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis in by Geography (USD MN)
Global Spinal Muscular Atrophy (Sma) Treatment Market Analysis in by Geography (USD MN)
Latin America Spinal Muscular Atrophy (Sma) Treatment Market by Revenue
Middle East & Africa Spinal Muscular Atrophy (Sma) Treatment Market by Revenue
Recent Development in Spinal Muscular Atrophy (Sma) Treatment Industry
Company Market Share Analysis, 2019

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "